@inproceedings{inproceedings, title  = {{Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer.}},

 url = {{}},

 year = {{2006}},

 month = {{1}},

 author = {{Poole CJ and Hiller L and Howard HC and Loi S and Dunn JA and Canney P and Wardley AM and Crown JP and Coleman RE and Verrill MW and Ellis PA et al}},

 volume = {{100}},

 journal = {{BREAST CANCER RESEARCH AND TREATMENT}},

 pages = {{S114-S114}},

 note = {{Accessed on 2025/10/10}}}